chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I thought I was going to get the first shot of the Moderna vaccine, it wasn't until the needle was in my arm that I was told I had received the Janssen vaccine.  At approximately 4:46pm I developed a strong pain at the injection site.  At approximately 8pm I began to run a  fever and feel extremely fatigued.  My back and all my joints started to ache, I was sweating but also freezing cold.  I had a dull, throbbing pain in my testes.  I had pain in my scalp, my eyebrows, my ear lobes, my fingernails, my toes and toenails, the soles of my feet hurt.  Least of all I also had a headache.   I took 500mg Ibuprofen for the pain.    Now, almost 48 hours later I still have a low grade fever, still have considerable pain at the injection site, still have a headache.  The remaining symptoms dissipated on 5/2/21 at about 12pm.  Took another 500mg Ibuprofen for breakfast, but otherwise have had no appetite since receiving the vaccine.
No immune response to vaccine; No immune response to vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-healthcare professional). The reporter is the patient. Other Case identifier(s): (RA). A 58-year-old male patient received BNT162b2 (BNT162B2), on 21Mar2021 as dose number unknown, single (Batch/Lot number: Unknown) at the age of 57 years for covid-19 immunisation. The patient relevant medical history included: "High Blood Pressure" (unspecified if ongoing), "Muscle Spasticity" (unspecified if ongoing), "Psoriasis" (unspecified if ongoing), "Broken Left Hand" (unspecified if ongoing), "Broken Left Ankle" (unspecified if ongoing), "Broken Right Arm" (unspecified if ongoing), "Stitches in Left Ear" (unspecified if ongoing, "Cane use" (unspecified if ongoing), "Multiple Sclerosis" (unspecified if ongoing), notes: Patient's concurrent condition. Concomitant medication(s) included: OCREVUS, LISINOPRIL, HYDROCHLOROTHIAZIDE, BACLOFEN. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "No immune response to vaccine".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pneumonia in right lung; Shooting pains in her chest; Cold; Sweats; Felt unwell; Fever up to 102.4 F; Shakes; A spontaneous report was received from a pharmacist for a 67 year old female patient who experienced pneumonia in right lung (pneumonia), shakes (tremors), felt unwell (malaise), cold (nasopharyngitis), fever up to 102.4 degrees Fahrenheit (pyrexia), sweating(hyperhidrosis), and shooting pains in chest (pain).   The patient's medical history was not provided. No concomitant product use was reported.  On 08 Mar 2021, the patient received the first of two planned doses of mRNA-1273 (Lot number: 048A21A) intramuscularly in left arm for prophylaxis of COVID-19 infection.   On 08-Mar-2021, an hour after the administration of vaccine, the patient felt unwell, was cold, had fever up to 102.4 degrees Fahrenheit, sweats, and shooting pains in chest.   On 10-Mar-2021, the patient went to emergency room and was diagnosed with pneumonia in the right lung. The symptoms were persisting at the time of the report.   Treatment information included paracetamol and doxycycline hydrochloride.  Action taken with mRNA-1273 was unknown.  The outcome of the events, pneumonia in right lung (pneumonia), shakes (tremors), felt unwell (malaise), cold (nasopharyngitis), fever up to 102.4 degrees Fahrenheit (pyrexia), sweating(hyperhidrosis) and shooting pains in chest (pain) is unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Had the vaccine got shingles/Suspected vaccination failure; Got shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient had the Shingles vaccine and still got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Raised knot on upper L arm approximately 5 cm in diameter, skin warm to touch, redness around raised area, hydrocortisone cream given to pt to apply to area as needed.
Within 1/2 hour bad funny taste in mouth, felt difficult to breathe for several seconds, saw bright light in front of her and then it all went away.
A nurse reported the occurrence of an injection site reaction in a 9-month-old female who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix).  The vaccinee had no relevant medical history and received no concurrent medications.  She had experienced no adverse events following previous vaccinations.  On 04/03/2002, the vaccinee received her third injection of Infanrix (Lot DTPA552A2) and her third injection of hepatitis B vaccine recombinant (Engerix-B, lot ENG5209C9).  At an unspecified time post-immunization on 04/03/2002, the vaccinee experienced an injection site reaction characterized by oval, red, hardness with spreading redness at the site of Infanrix administration.  Additionally, the vaccinee experienced an injection site reaction at the Engerix-B injection site also characterized by oval, red, hardness with spreading redness.  The vaccinee was seen by a physician on 04/04/2002.  The physician prescribed paracetamol (Tylenol) and cold compresses.  The reporter stated that the injection site reactions were probably related to vaccine administration.  The injection site reactions resolved on 04/05/2002.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with Engerix B for prophylaxis. Concurrent medical conditions included dialysis. Subjects had previously received Recombivax and did not respond to therapy. On an unspecified date the subject received unspecified dose of Engerix B (unknown). At an unspecified time after vaccination with Engerix B, the subject did not respond to therapy as laboratory results did not show anti-hepatitis b antibodies. At the time of reporting the outcome of the event was unspecified.
Fussy x2 hours after imms. Temp 100.7. No redness at site.
Breakthrough case after two vaccines  Pfizer 4/14/21 Lot#EN6204;  Pfizer 10/18/21 Lot# FF8841
March 26 2021=  1st does of Pfizer vacc  site pain and heaviness of limbs  April 1 2021= woke up at 3 am with chest discomfort MD visit=high blood pressure(BP) and EKG (normal), prescribed HCTZ 25 mg daily ER visit=chest discomfort/dizziness/heaviness in arms blood work=low sodium. EKG=normal, high BP  April 4 2021 ER visit=insomnia/dizziness/globilized weakness/muscle spasm Given IV and pain meds, no labs or test were done stopped taking HCTZ  April 5 2021= ER visit=Facial drop (right side), weakness,back spasm, feeling of ants on face/chest and arms blood work to check sodium=normal, bp=normal, given blood pressure meds and sent home (not very good doctors)  April 6 2021= Taking HCTZ due to swelling facial drop    April 6 2021= Taking HCTZ due to swelling facial drop  was gone (face back to normal) started taking baby aspirin ASA due to recommendation of aunt (who is a doctor) CT HEAD=normal  April 7 2021=Taking hctz and ASA daily started monitoring BP at home dizziness and head aches took exedrin  bp normal all day  April 8-13 2021  Chest discomfort and pain (would move sides depending of the day) insomnia (1 night) tension headaches muscle spasm on and off feeling of ants on arms no MD visit or ER visit during this time BP normal during this time  during this time i did not believe that my symptoms were due to the vaccine/ i thought it was lasting effects of covid (covid long hauler)  April 14 2021=2nd dose vaccine pfizer  April 14-19 symptoms persisted but intensity and frequency subsided  the chest discomfort was duller no more feeling of ants minor swelling of the throat (could still breath,drink and talk) cut HCTZ dosage in half bp normal  April 20 2021 Chest discomfort in the night (like on april 1) discomfort would not let me sleep bp normal all day  April 21 2021 muscle spasm on neck and back burning sensation in left side chest going to the left arm  April 22 2021 MD visit  (did not believe me when i told him it may be side effects of vaccine) refferal for blood test (no results yet)  April 23 2021 stopped taking diuretic hot face(no fever 37.6 C) swelling of face (these symptoms started around 7 am) Took Benadryll bp normal  ER visit (different hospital than other visits) tingling on left arm and face (right side) (around 1 pm) facial drop (right side) bp high EKG=normal/CT scan=normal/chest x ray=normal/covid, influenza and microplasma=negative/ blood work =normal (electrolytes ok)/troponin=.017/urinalysis=normal given benadryll and saline solution IV told that these are symptoms of the vaccine and to ride it out with aspirin and benadryll  April 24 2021 (today) hot face, swelling of hands (for now its early in the day) no bp readings yet  Seeing that the symptoms were restarting at around the same timeframe as the first dose I now think that these may be secondary effects of the vaccine
Hospitalization for COVID symtpoms on dates 7/4/22-7/7/22. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
began as exhaustion around 8pm, went to bed, woke up several times- looked at the clock once at 3am.  sx included profuse sweating, dizziness, insomnia, racing heart.  kept drinking water, stayed in bed until 11am sleeping off and on.  got up and headed to bathroom, felt nauseous for a little bit.  while getting a glass of water, room began to grow dark.  thought i needed to fix an electrolyte balance , and headed to the kitchen to get juice.  next thing i know, i am lying on the ground, on my back, in front of the fridge.  i was near the snack cabinet. so i reached in and ate some corn cakes.  then i got up, drank more water and juice, and went back to bed.  all total the day after the vaccine, i was awake 3 hours and slept the rest.  i continued with some back pain, and thought is was from too much sleeping.  turns out, in the shower i found a pretty nasty abrasion on my back- that's when i realized i had passed out.  i had landed on the corner of a small step stool, and then later found out i had cracked two ribs.  my PCP had heard another story of a healthy woman who had gotten COVID #2 and passed out.  she reminded me that i have really healthy blood pressure, sometimes bordering on low, and thinks that might have contributed...but i was not ok for several days after shot 2.  i took 1/2 a day that monday (shot was Friday) and didn't feel ok to drive for several days- still felt dizzy and out of it.  finally went for a run (which i normally do daily) around day 5.
PT RECEIVED 2ND DOSE OF PFIZER VACCINE, WAS WAITING IN THE POST VACC WAITING AREA THEN SHE ASKED FOR WATER.  SHE APPEARED GLASSY-EYED AS SHE WAS APPROACHING THE COUNTER SO I WALKED OUT TO ASK IF SHE WAS OK.  AS SOON AS I GOT OUT THERE, SHE STARTED TO FAINT.  WE CAUGHT HER AND HAD HER LAYING ON THE MAT WHILE EMS WAS CALLED.  BLOOD PRESSURE WAS 112/84 P 106 (TOOK THIS AFTER SHE REGAINED CONSCIOUSNESS IN A FEW SECONDS).  WHEN SHE CAME TO, SHE SAID SHE HAD NOT EATEN RECENTLY, HAD ONLY HAD COFFEE TO DRINK TODAY, SO HAD HER LIE DOWN WITH HER FEET ELEVATED.  SHE BEGAN TO VOMIT INTO THE TRASHCAN.  EMS ARRIVED, EVALUATED HER AND ALL VITALS WERE NORMAL, SHE SAID THAT SHE HAD PASSED OUT PREVIOUSLY AFTER A VACCINE, BUT DID NOT INDICATE THAT ON HER QUESTIONNAIRE (PCQF).
The evening after dose 3, 05/17/2022, my arm swelled up.  That lasted a week or two.  I had no energy.  I can still tell a difference. I still have loss of taste and smell.
Nausea; Vomiting; Headache; Burning in esophagus; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 21Mar2021 at 17:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The medical history included hyperthyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included lamotrigine (LAMICTAL), gabapentin (MANUFACTURER UNKNOWN), duloxetine hydrochloride (CYMBALTA), baclofen (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all taken for unknown indications from unknown dates and unknown if ongoing. On 23Mar2021, the patient experienced nausea, vomiting, headache and burning in esophagus. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the reported events and included treatment with ondansetron (ZOFRAN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, headache and burning in esophagus was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
first  dose in March 2020 and  second  dose in July 2021; This case was reported by a consumer and described the occurrence of drug dose administration interval too long in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in March 2020).   In July 2021, the patient received the 2nd dose of Shingrix. In July 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The reporter was the patient. The reporter stated that, received 2nd dose later than the recommended time interval, whch led to lengthening of vaccination schedule. The reporter consented to follow up.
12 hours after vx she developed a small rash, then over the course of the next 2 weeks the rash grew to 1/2 of her arm. Dr. prescribed Prednizone
I felt a heart flutter in my chest my husband took me to the ER. My blood pressure was elevated. All test came back negative. I followed up with Cardiologist for Stress Test and Heart Monitor all the events happened on May 10. Nothing has been resolved.
This case was reported by a physician and described the occurrence of not responding to therapy in a 20-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline), Hep B. On an unspecified date the subject received 3rd dose of ENGERIX B (.5 ml, unknown), 2nd dose and 1st dose of Hep B (unknown). On an unspecified date after vaccination series completion with ENGERIX B and Hep B, the subject experienced not responding to therapy. The physician reported the subject tested negative for hepatitis B antigen and antibody on a recent test. The subject completed the vaccination series "years ago", but the mother was antigen positive. Relevant test results included Hepatitis B antigen and antibody negative. The healthcare professional reported another case regarding ENGERIX B, see case A0890089A. Follow-up information was received on 16 November 2010 via physician who refused to be contacted. At the time of the report no other information was provided.
Initial information received on 19-Jul-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves unknown demographic patient who experienced itching all over his body, while he/she received vaccine TYPHIM VI. The patients past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect TYPHIM VI lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious itching all over his body (pruritus generalised) (Unknown latency) following the administration of TYPHIM VI. (Other relevant tests included No lab data.) Final diagnosis was itching all over his body. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for itching all over his body. List of documents held by sender: none.
Developed rash and swelling of face approximately 24 hours after dose. Took BENADRYL PO and was seen by PCP who prescribed oral steroid. Uneventful resolution of sx. No tx sought by pt until 1/8/10!
My arm and fingers were tingly and my arm was sore for at least 2-3 days. It felt very heavy and tingly.
Felt like having the actual flu, when its signs/symptoms are most severe. All-over body ache, very painful at injection site/arm. Constant chills, fever that lasted through the next day. Nausea.
Pt. received MMR and VARIVAX subcutaneous to right upper leg. Within 5 minutes developed large red hive to area of injection. Pt was given oral BENADRYL; no wheezing.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old female patient who received SHINGRIX for prophylaxis. In November 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left arm. The patient received a dose in the 1st week of November and she said it felt like she was punched in the arm. The soreness lasted for 4 to 5 days. Consent to follow up was provided.
23FEB93 site red, not temp; 24FEB93 bruised discolored area; seen by MD w/localized/reaction/infection;
Initial report was received 10 January 2011 from a health care professional. A five-year-old patient experienced an anaphylactic reaction to a vaccine (presumably a DTP vaccine) five years ago (manufacturer, lot number, route, site and date of administration not reported). The patient's age at the time of the event was not reported. At the time of the report, the physician had not yet seen the record. No additional information was provided. Documents held by sender: None.
Per pts daughter, pt went to ER, had redness, swelling, confusion, "fever in arm", black dot where vaccination was administered.
Cough, chest spasm, light headed, dizzy. 25 mg BENADRYL adm. - monitored x 20 more min. 120/78, RR 18, AP 75. Encouraged to seek medical treatment.
Diagnosed with HSV2 on April 5, 2021. 14 yr monogamous relationship
Shortness of breath, Myalgia, Malaise and fatique, chills without fever, not able to exercise the 5 miles daily routine since the vaccine. Short winded with regular day to day housework. No chest pain. fatigue continued for weeks after initial vaccine. Symptoms continued. Arm swollen and red for days after vaccine. No travel. no sick contacts. no wheezing, no cough. no leg swelling or leg pain. no headaches, no change in taste or smell. No GI symptoms, No history of blood clot bleeding disorder. Does have history of colon cancer
had another bells palsy after the first Pfizer booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): MOD22-017831.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "COPD" (unspecified if ongoing); "covid 19", start date: Nov2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization, reaction(s): "bells palsy"; Bnt162b2 (Dose 2), for COVID-19 Immunization. The following information was reported: BELL'S PALSY (medically significant), outcome "unknown", described as "had another bells palsy after the first Pfizer booster". Caller said they initially took 2 Pfizer doses and 1 Pfizer booster. Caller reported getting bells palsy after the first Pfizer injection. Then they had another bells palsy after the first Pfizer booster. Now caller is at the second booster and it is Moderna. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200019699 same patient/drug/AE, different dose number;
This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 26-year-old female patient who received FLUARIX. Previously administered products included gentamicin (Patient has had a previous minor reaction to a gentamicin containing medication). Concurrent medical conditions included food allergy (Patient has multiple food allergies). In September 2014, the patient received FLUARIX (injection). On an unknown date, an unknown time after receiving FLUARIX, the patient experienced injection site erythema, injection site swelling, injection site pain, feels poorly nausea. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site pain feels poorly and nausea were recovered/resolved. The reporter considered the injection site erythema, injection site swelling, injection site pain, feels poorly and nausea to be probably related to FLUARIX. Additional information received: Clinic manager reports that a patient received FLUARIX 0.5 mL in September. She immediately experienced a moderate local reaction that consisted of pain, redness, and swelling. She also developed a systemic reaction of nausea and feeling poorly. These symptoms resolved 8 days after receiving the vaccine.
Injection was given subcutaneously rather intramuscularly as it should have been.  As a result my entire upper arm became red, swollen, and painful/itchy.  I had to take a combination of Allegra-D and Benedryl for five days to resolve the reaction.
Headache, body ache, ache at injection site, chills, loss of balance, one episode of fainting, one episode of vomiting
Information has been received from a registered nurse concerning her daughter, with possible allergy to aluminum. The patient subsequently experienced a knot in arm around injection site and pruritus while on therapy with hepatitis B virus vaccine (manufacturer unknown) (WAES # 0706USA05089). The patient was vaccinated IM with a 0.5 ml second dose of Gardasil. Subsequently the patient experienced "knot in her arm around the injection site." The area was swollen and warm th the touch. Unspecified medical attention was sought. It was reported that the patient had an ultrasound that revealed a knot in muscle. It was reported it took 1 month before her symptoms resolved. Subsequently, the patient recovered from "knot in her arm around the injection site", swollen and warm to the touch. It was reported that the patient did not experience any adverse event after the first dose of the vaccine. Additional information has been requested.